AKAN - AKANDA CORP.


1.17
-0.050   -4.274%

Share volume: 43,702
Last Updated: 04-07-2025
Pharmaceutical Products/Medicinal Chemicals: -0.09%

PREVIOUS CLOSE
CHG
CHG%

$1.22
-0.05
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
15%
Profitability 0%
Dept financing 25%
Liquidity 0%
Performance 30%
Performance
5 Days
-12.03%
1 Month
-22.52%
3 Months
-26.88%
6 Months
5.41%
1 Year
874.19%
2 Year
-97.71%
Key data
Stock price
$1.17
P/E Ratio 
0.00
DAY RANGE
$1.12 - $1.22
EPS 
N/A
52 WEEK RANGE
$0.08 - $5.66
52 WEEK CHANGE
$869.35
MARKET CAP 
15.256 M
YIELD 
N/A
SHARES OUTSTANDING 
11.930 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
3.75
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$24,410
AVERAGE 30 VOLUME 
$25,421
Company detail
CEO: Tejinder Virk
Region: US
Website: akandacorp.com
Employees: 110
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Akanda Corp. engages in the cultivation, manufacture, and distribution of cannabis products. It intends to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Recent news
loading